Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study-Reference-Cited by-同舟云学术

Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study

Published:2022-10 Issue: Volume:365 Page:34-40
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Prescott Eva,Angerås Oskar,Erlinge David,Grove Erik L.,Hedman Marja,Jensen Lisette O.,Pernow John,Saraste Antti,Åkerblom Axel,Svedlund Sara,Rudvik Anna,Knöchel Jane,Lindstedt Eva-Lotte,Garkaviy Pavlo,Gan Li-Ming,Gabrielsen Anders

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013;Lancet,2015

2. Antiinflammatory therapy in clinical care: the CANTOS trial and beyond;Aday;Front. Cardiovas. Med.,2018

3. Leukotrienes;Peters-Golden;N. Engl. J. Med.,2007

4. Initial clinical experience with AZD5718, a novel once daily oral 5-lipoxygenase activating protein inhibitor;Ericsson;Clin. Transl. Sci.,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine in Acute Coronary Syndromes;Journal of Clinical Medicine;2024-08-05

2. Emerging Therapeutic Targets for Acute Coronary Syndromes: Novel Advancements and Future Directions;Biomedicines;2024-07-26

3. Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases;Circulation Research;2024-06-21

4. Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators;Frontiers in Pharmacology;2023-08-23

5. Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein;ACS Omega;2023-08-18